Compulsory
Storage and Distribution Standards in Drug Rules Soon, Draft Rules Released for
30 days Consultation Window
The Ministry of Health and Family Welfare has
published draft amendments to the Drugs Rules, 1945 (Notification G.S.R.
984(E), dated November 4, 2026) to legally mandate compliance with Good
Distribution Practices (GDP) across India's pharmaceutical supply chain.
Key
Highlights
·
Formal Definition Added:
Introduces a new sub-rule under Rule 2 defining "Guidelines on Good
Storage and Distribution Practices (GSDP) for Pharmaceutical Products"
as the standards formulated by the Central Drugs Standard Control Organisation
(CDSCO) and adopted by the Drugs Technical Advisory Board (DTAB).
·
Mandatory Compliance Across License Types: Inserts
a direct condition requiring licensees to ensure compliance with the Good
Distribution Practices Guidelines across multiple licensing categories under
the Drugs Rules, 1945:
o
Import Licenses: Rules 26 and 33A
o
Sale & Distribution Licenses: Rule 65
o
Manufacturing & Loan Licenses: Rules
74, 74A, 74B, 78, and 78A
o
Blood Centre / Blood Bank Licenses: Rule
122P
·
Public Consultation Window: The
Central Government is inviting objections and suggestions from stakeholders
within 30 days from the date the Gazette copies are made available to
the public. Feedback can be sent by post to the Under Secretary (Drugs),
Ministry of Health and Family Welfare (Kartavya
Bhavan 1, New Delhi) or emailed to drugsdiv-mohfw@gov.in.
·
Effective Date: The final rules will come into
force on a date specified by the government upon final publication in the
Official Gazette.